Craig Wheeler "director", who manages to sell a ton of stock at best prices. He is the enemy of stock holders. Selling $10 million of MNTA (just last year!) while screwing-up every deal he ever made.
If MNTA's claim is considered equal to Classen, the stock is damaged greatly. Classen's "invention" is a dose schedule. Hardly much of anything. For MNTA, All the work that went into developing a method for determining the contents of an extremely complex chemical was essentially given-away with the patent publication. The Solicitor General is not helping, the refusal to en bank is not helping and I have little faith in the Supreme Court to really understand how MNTA has been harmed. The inventors have made millions already. If the company was too stupid to keep their secret behind closed doors, then we investors have bought into a dog that just won't hunt.
Nine strikes and the whole side is out! I am not sure what team is at bat now; but it is not MNTA. Even a "tentative" copaxone approval would not have the energizing effect on stock price. MNTA has become a "one-trick pony" who's trick can be done anywhere.
I did not see a rush of buying after the pitch by Rick Shea:
Richard P. Shea has been our Senior Vice President and Chief Financial Officer since July 2007. From October 2003 through July 2007, he served as our Vice President and Chief Financial Officer. From April 2002 to April 2003, Mr. Shea served as Chief Operating Officer for Variagenics, Inc., a pharmacogenomics company. From March 2000 to April 2002, Mr. Shea served as Variagenics, Inc.'s Chief Financial [...] more
Momenta Pharmaceuticals, Inc.
Compensation for 2011
Restricted stock awards
All other compensation
Non-equity incentive plan compensation
But they keep selling it and driving the price down. Give the officers options that have value if the stock goes up. If they take the deal you know they have confidence. Otherwise it is just talk. Only VENKATARAMAN remains with any specialized knowledge and MNTA gave away the secret already.
I don't get it. Beyond posting your vacation photos so that your friends are jealous about you standing next to the taj mahol or the sphinx, what does it add? I wish there was a better substitute for #$%$ yahoo; they want to be like FB!!
Need proof of the cheating that goes on in Wall Street. After hours we often see spikes in the chart as brokers register trades made earlier. Had those trades been registered in real time they may have changed the direction of the market. Registering the trade after hours is considered "Honest".
Cramer is the master scammer. I stopped watching him and I am doing much better. All his head fakes, phoney pumps for his friends and nonsense is just a waste of one hour each day.
It is huge. If MNTA can sell copaxone it not only increases the bank account but it tells the world that they are not a "one-trick pony."
We see this all play out in short order. I think all would agree that the overwhelming impression that was made here and on iHub that MNTA has good chances. Information from the company has been crap, so those who are long rely on these boards. So I will certainly forgive some hostility from those who bought the party line. I remain hopeful.
When you put on a show in your garage it is good to have Judy Garland and Mickey Rooney on your block. A few great scientists may not make the best business. We are lucky they did as well as they did. I have bet big that all this is not for show and that the future is award winning.
Per DD on the other board: "The new launch is an “authorized generic” from Sanofi, the maker of branded Lovenox. The AG is the exact same product as branded Lovenox except for the packaging and (presumably) a slightly lower price."
Yet our "partner" made sure to call it a new entry into the market. SNY launched the AG to weaken MNTA, our partner helps them. Some people think it will weaken our case against Amph. I don't, I think they cheated and that is the question in front of the Judge.
The royalty profit sharing was easy to follow. In fact it was the huge penalty for a second generic that gave a false sense of protection. How could we know that if SNY just issues another package, Sandoz would count that as another competitor! With partners like this it is no surprise that there are still 5 million shorts.
I am also very long and I have seen nothing but bad news lately. This administration has done nothing to protect shareholders interest. By Friday we will know if they should clean-out their offices.
If I had the chance to buy a company with half its value in cash, a good (now not great) cash stream and potential for another payday; I would be a buyer. So I have to stick with my MNTA.
I agree that management has made several absolute blunders that allowed shorts to control everything and other companies to act with impunity.
It is tough to score in this league when you only play defense. Let's see if our lawyers in the patent court are a little better than the guys who wrote the profit sharing on Enox.